Clinical Trial

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

Completed
View on ClinicalTrials.gov →
Summary
Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited. Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.
Trial Details
NCT Number NCT07419074
Lead Sponsor University of Lahore
Conditions Lipid Profile
Enrollment 90 participants
Start Date 2025-09-01
Primary Completion 2025-11-24 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-18